Clinical Research Detail Title Of Study This study is to evaluate the efficacy and safety of 2 different doses of canagliflozin compared with placebo in older patients (55 to 80 years of age) with type 2 diabetes mellitus (T2DM) with inadequate control on their current diabetes treatment regimen. Disease Condition Type 2 Diabetes Mellitus Phase of Trial Phase-3 Discipline Diabetology Start date of Trial 5/3/2010 Closing Date of Trial 5/3/2014 If you are a doctor interested in clinical research then upload your profile. Click here If you are a hospital interested in clinical research then upload your profile. Click here If you are a patient interested to know more about this clinical trial mail us at:   [email protected]